Saudi FDA: Working with Industry to Improve the Reporting of Adverse Reactions

Add bookmark

Saudi FDA: Working with Industry to Improve the Reporting of Adverse Reactions

Add bookmark
In this interview Dr. Nasser Al-Qahtani, Head, Adverse Drug Reactions Evaluation Department Saudi FDA speaks to Andrea Charles from Pharma IQ, about the Saudi FDA pharmacovigilance system and what new guidelines he predicts will be areas for discussion amongst pharma/bio companies in 2012. Dr. Nasser Al-Qahtani shares his insights on the impact of social media on the pharmacovigilance system and the initiatives the Saudi FDA are planning to imple...

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended